POHCA Resuscitation: Evaluation of IM Epinephrine

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 284 participants.

Also called NCT05166343

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 2/3
Enrolled
  • 284 participants (planned count) (from the registry)
Registry
  • NCT NCT05166343
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05166343. Randomized; no masking; primary purpose supportive care. Start 2024-01-08 (actual); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
POHCA Resuscitation: Evaluation of IM Epinephrine
Acronym
PRIME
Condition
Pediatric Out-of-Hospital Cardiac Arrest
Intervention (Drug)
Epinephrine Injection
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (class: other)

Record details

Record id
cardio:ct-nct05166343
Content hash
4446015987201a8e0a845974d384429c28acad2ee9daf69a13cd6c34478b0945